Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril-amlodipine vs Perindopril-indapamide in Newly Diagnosed Hypertensive T2D Patients
NCT03747978Phase 4Completed
- Sponsor
- Yaoundé Central Hospital
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of perindopril and amlodipine in hypertension (HTN) (2 arms), sponsored by Yaoundé Central Hospital. Primary endpoint: 24-hour blood pressure at 6 weeks. Started Oct 2016; status: completed.
02
Drugs
perindoprilamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03747978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03747978.